tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

Compare TScan Therapeutics (TCRX) vs. Competitors

Compare
313 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
TScan Therapeutics
$0.96
$54.56M
-0.86
-60.45%
4 Buy
2 Hold
0 Sell
Moderate Buy
Zentalis Pharmaceuticals
$1.41
$184.24M
-1.22
56.44%
4 Buy
2 Hold
0 Sell
Moderate Buy
ALX Oncology Holdings
$2.01
$108.98M
-0.99
55.81%
3 Buy
1 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.56
$189.18M
-2.74
-31.28%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$23.65
$202.71M
-1.08
109.11%
3 Buy
0 Hold
0 Sell
Strong Buy
Instil Bio
$7.16
$50.32M
-0.65
-67.12%
0 Buy
2 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TCRX
TScan Therapeutics
0.96
-1.41
-59.45%
ZNTL
Zentalis Pharmaceuticals
2.55
0.39
18.06%
ALXO
ALX Oncology Holdings
2.01
0.81
67.50%
IKT
Inhibikase Therapeutics
1.56
-0.87
-35.80%
SRZN
Surrozen
23.65
12.55
113.06%
TIL
Instil Bio
7.42
-16.02
-68.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts